Compliance With PROMs Detection Through Digital Support and Correlation Compared to Standard Outpatient PROMs Detection in Hip Prosthetics (DIG-PROMs-h) (DIG-PROMs-h)

May 20, 2026 updated by: Istituto Ortopedico Rizzoli

Compliance al Rilevamento PROMs Mediante Supporto Digitale e Correlazione Rispetto al Rilevamento PROMs Ambulatoriale Standard Nella Protesica d'Anca

Two methods for detecting outcomes after hip prosthetic surgery are compared: the traditional one using paper questionnaires administered in the outpatient setting (WOMAC Score) VS detection using digital questionnaires created on Google Forms and sent to the patient's smartphone on which the compilation takes place in the extra area outpatient.

Study Overview

Status

Recruiting

Conditions

Detailed Description

PROMs (Patient Reported Outcomes Measures) are used globally for the evaluation of the results of a prosthetic surgery. One of the most used methods in the evaluation of PROMs in hip prosthetic surgery is the WOMAC Score, usually measured in an outpatient setting using paper questionnaires.

The aim of the study is to investigate the validity of an alternative method of evaluating PROMs in which the questionnaire will be administered to the patient digitally (Google Forms) in an out-of-patient setting.

The questionnaire aimed at the subjective evaluation of the discomfort induced by arthrosis of the hip (WOMAC Score), will be administered during the pre-hospitalization visits and again during the follow-up visits carried out at 1, 3 and 6 months after intervention. The digital evaluation will be sent to the patient during the outpatient visits and will be considered valid only if completed within 48 hours of the same.

On each patient the measurements will be carried out in both methods and differences in terms of compliance and satisfaction with the two methods under examination will be detected. Any differences in the final result of the WOMAC Score compared to the two methods and the differences in terms of outpatient assessment times will also be evaluated.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Italia
      • Bologna, Italia, Italy, 40136
        • Recruiting
        • Istituto Ortopedico Rizzoli
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 74 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patients with coxarthrosis with indication of hip arthroplasty
  • males and females aged 18-78 and with a Barthel scale score ≥ 91
  • patients in possession of private digital electronic support (smartphone, tablet or PC)

Exclusion criteria:

  • patients with a Barthel scale score ≤ 90
  • patients with psychiatric pathologies, a history of drug and alcohol abuse
  • patients not in possession of private digital electronic support

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: DIG-PROMs-h
Patients who underwent THA are given conventional and digital surveys of the WOMAC index. Patients adhesion to both surveys will be compared.
The aim of the study is to investigate the validity of an alternative method of evaluating PROMs in which the questionnaire will be administered to the patient digitally (Google Forms) in an out-of-patient setting.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient's adhesion to the digital compilation after the pre-admission visit
Time Frame: 1 month before surgery (pre-admission outpatient visit)

Adhesion: The primary end point will be assessed in terms of patient adhesion at the digital survey of the WOMAC index compared to the conventional one.

Those who complete the questionnaire within 48 hours of the outpatient visit will be considered as cases with positive adhesion with the digital assessment; those who reply after 48 hours or who do not reply will be considered with negative adhesion.

1 month before surgery (pre-admission outpatient visit)
Patient's adhesion to the digital compilation one month after surgery
Time Frame: 1 month after surgery (follow up visit)

Adhesion: The primary end point will be assessed in terms of patient adhesion at the digital survey of the WOMAC index compared to the conventional one.

Those who complete the questionnaire within 48 hours of the follow up visit will be considered as cases with positive adhesion with the digital assessment; those who reply after 48 hours or who do not reply will be considered with negative adhesion.

1 month after surgery (follow up visit)
Patient's adhesion to the digital compilation three months after surgery
Time Frame: 3 months after surgery (follow up visit)

Adhesion: The primary end point will be assessed in terms of patient adhesion at the digital survey of the WOMAC index compared to the conventional one.

Those who complete the questionnaire within 48 hours of the follow up visit will be considered as cases with positive adhesion with the digital assessment; those who reply after 48 hours or who do not reply will be considered with negative adhesion.

3 months after surgery (follow up visit)
Patient's adhesion to the digital compilation six months after surgery
Time Frame: 6 months after surgery (follow up visit)

Adhesion: The primary end point will be assessed in terms of patient adhesion at the digital survey of the WOMAC index compared to the conventional one.

Those who complete the questionnaire within 48 hours of the follow up visit will be considered as cases with positive adhesion with the digital assessment; those who reply after 48 hours or who do not reply will be considered with negative adhesion.

6 months after surgery (follow up visit)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of coherence between the WOMAC score detected on an outpatient basis by means of a paper questionnaire and that detected by digital extra-ambulatory administration one month before surgery
Time Frame: 1 month before surgery (pre-admission outpatient visit)

As a secondary end point, the level of coherence between the WOMAC score detected on an outpatient basis by means of a paper questionnaire and that detected by digital extra-ambulatory administration will be examined, one month before surgery, on the occasion of the pre-admission visit.

Which and how many responses will be discordant with respect to the two types of survey will be indicated.

1 month before surgery (pre-admission outpatient visit)
Level of coherence between the WOMAC score detected on an outpatient basis by means of a paper questionnaire and that detected by digital extra-ambulatory administration one month after surgery
Time Frame: 1 month after surgery (follow up visit)

As a secondary end point, the level of coherence between the WOMAC score detected on an outpatient basis by means of a paper questionnaire and that detected by digital extra-ambulatory administration will be examined, one month after surgery, on the occasion of the follow up visit.

Which and how many responses will be discordant with respect to the two types of survey will be indicated.

1 month after surgery (follow up visit)
Level of coherence between the WOMAC score detected on an outpatient basis by means of a paper questionnaire and that detected by digital extra-ambulatory administration threee months after surgery
Time Frame: 3 months after surgery (follow up visit)

As a secondary end point, the level of coherence between the WOMAC score detected on an outpatient basis by means of a paper questionnaire and that detected by digital extra-ambulatory administration will be examined, three months after surgery, on the occasion of the follow up visit.

Which and how many responses will be discordant with respect to the two types of survey will be indicated.

3 months after surgery (follow up visit)
Level of coherence between the WOMAC score detected on an outpatient basis by means of a paper questionnaire and that detected by digital extra-ambulatory administration six months after surgery
Time Frame: 6 months after surgery (follow up visit)

As a secondary end point, the level of coherence between the WOMAC score detected on an outpatient basis by means of a paper questionnaire and that detected by digital extra-ambulatory administration will be examined, six months after surgery, on the occasion of the follow up visit.

Which and how many responses will be discordant with respect to the two types of survey will be indicated.

6 months after surgery (follow up visit)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2020

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

December 23, 2020

First Submitted That Met QC Criteria

February 8, 2021

First Posted (Actual)

February 11, 2021

Study Record Updates

Last Update Posted (Actual)

May 22, 2026

Last Update Submitted That Met QC Criteria

May 20, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • CE-AVEC 583/2020 / Oss / IOR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Extrambulatory digital PROMs detection

Subscribe